These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10068105)

  • 1. Course of platelet counts in cirrhotic patients after implantation of a transjugular intrahepatic portosystemic shunt--a prospective, controlled study.
    Gschwantler M; Vavrik J; Gebauer A; Kriwanek S; Schrutka-Kölbl C; Fleischer J; Madani B; Brownstone E; Tscholakoff D; Weiss W
    J Hepatol; 1999 Feb; 30(2):254-9. PubMed ID: 10068105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.
    Karasu Z; Gurakar A; Kerwin B; Hulagu S; Jazzar A; McFadden R; Nour B; Sebastian A; Cassidy F; Stokes K; Van Thiel DH; Wright H
    Dig Dis Sci; 2000 Oct; 45(10):1971-6. PubMed ID: 11117569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in hematologic and hemostatic parameters after transjugular intrahepatic portosystemic shunt (TIPS) implantation].
    Papp M; Mezei G; Udvardy M; Altorjay I
    Orv Hetil; 2003 Jul; 144(27):1341-5. PubMed ID: 12908147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.
    Barney EJ; Little EC; Gerkin RD; Ramos AX; Kahn J; Wong M; Kolli G; Manch R
    Dig Dis Sci; 2012 Sep; 57(9):2430-7. PubMed ID: 22588242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does transjugular intrahepatic portosystemic shunt (TIPS) resolve thrombocytopenia associated with cirrhosis?
    Jabbour N; Zajko A; Orons P; Irish W; Fung JJ; Selby RR
    Dig Dis Sci; 1998 Nov; 43(11):2459-62. PubMed ID: 9824134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients.
    Alvarez OA; Lopera GA; Patel V; Encarnacion CE; Palmaz JC; Lee M
    Am J Gastroenterol; 1996 Jan; 91(1):134-7. PubMed ID: 8561113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.
    Massoud OI; Zein NN
    Gastroenterol Hepatol (N Y); 2017 May; 13(5):286-291. PubMed ID: 28656025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and splanchnic endothelin-1 plasma levels in liver cirrhosis before and after transjugular intrahepatic portosystemic shunt (TIPS).
    Nolte W; Ehrenreich H; Wiltfang J; Pahl K; Unterberg K; Kamrowski-Kruck H; Schindler CG; Figulla HR; Buchwald AB; Hartmann H; Ramadori G
    Liver; 2000 Feb; 20(1):60-5. PubMed ID: 10726962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-Harmonic Elastography of the Liver is Sensitive to Intrahepatic Pressure Gradient and Liver Decompression after Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation.
    Tzschätzsch H; Sack I; Marticorena Garcia SR; Ipek-Ugay S; Braun J; Hamm B; Althoff CE
    Ultrasound Med Biol; 2017 Mar; 43(3):595-600. PubMed ID: 27979668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.
    Lawrence SP; Lezotte DC; Durham JD; Kumpe DA; Everson GT; Bilir BM
    Dig Dis Sci; 1995 Jul; 40(7):1575-80. PubMed ID: 7628285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of transjugular intrahepatic portosystemic shunt on glycometabolism in cirrhosis patients.
    Su AP; Cao SS; Le Tian B; Da Zhang Z; Hu WM; Zhang Y; Wang ZL; Babu SR; Hu T
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):53-9. PubMed ID: 22099870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCL9 is a prognostic marker in patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt.
    Berres ML; Asmacher S; Lehmann J; Jansen C; Görtzen J; Klein S; Meyer C; Strunk HM; Fimmers R; Tacke F; Strassburg CP; Trautwein C; Sauerbruch T; Wasmuth HE; Trebicka J
    J Hepatol; 2015 Feb; 62(2):332-9. PubMed ID: 25457205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunt: short-term and long-term effects on hepatic and systemic hemodynamics in patients with cirrhosis.
    Lotterer E; Wengert A; Fleig WE
    Hepatology; 1999 Mar; 29(3):632-9. PubMed ID: 10051460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study.
    Wong RJ; Ge J; Boike J; German M; Morelli G; Spengler E; Said A; Desai A; Couri T; Paul S; Frenette C; Verna EC; Goel A; Fallon M; Thornburg B; VanWagner L; Lai JC; Kolli KP
    J Vasc Interv Radiol; 2023 Aug; 34(8):1364-1371. PubMed ID: 37100199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of intrahepatic portosystemic shunting after placement of a transjugular intrahepatic portosystemic shunt.
    Walser EM; Harris VM; Harman JT; Park HM; Siddiqui AR
    J Vasc Interv Radiol; 1996; 7(2):263-7. PubMed ID: 9007808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic adaptation two months after transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients.
    Colombato LA; Spahr L; Martinet JP; Dufresne MP; Lafortune M; Fenyves D; Pomier-Layrargues G
    Gut; 1996 Oct; 39(4):600-4. PubMed ID: 8944572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The presence of spontaneous portosystemic shunts increases the risk of complications after transjugular intrahepatic portosystemic shunt (TIPS) placement.
    Borentain P; Soussan J; Resseguier N; Botta-Fridlund D; Dufour JC; Gérolami R; Vidal V
    Diagn Interv Imaging; 2016 Jun; 97(6):643-50. PubMed ID: 26947721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.